Anhydrase carbonique
L'anhydrase carbonique est une enzyme qui catalyse la conversion réversible du dioxyde de carbone et de l'eau en bicarbonate et protons. Cette enzyme joue un rôle crucial dans le maintien de l'équilibre acido-basique, la respiration et le transport du dioxyde de carbone dans le sang. Les inhibiteurs de l'anhydrase carbonique sont utilisés dans le traitement du glaucome, de l'épilepsie et du mal des montagnes, ainsi que dans la recherche sur l'homéostasie acido-basique et les échanges gazeux. Chez CymitQuimica, nous offrons une gamme d'inhibiteurs de l'anhydrase carbonique et de réactifs de haute qualité pour soutenir vos recherches en enzymologie, physiologie respiratoire et développement thérapeutique.
177 produits trouvés pour "Anhydrase carbonique"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
hCAXII-IN-5
CAS :<p>hCAXII-IN-5, or compound 6o, is a potent, selective hCAXII inhibitor with Ki values: hCAI & II >10000, hCAIX 286.1, hCAXII 1.0 nM.</p>Formule :C23H22N2O4Couleur et forme :SolidMasse moléculaire :390.43AHR-15010
CAS :<p>AHR-15010 is a novel anti-arthritic agent.</p>Formule :C10H16N2O8S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :356.37L-693612 HCl
CAS :<p>L-693612 HCl is an inhibitor of carbonic anhydrase.</p>Formule :C14H25ClN2O5S3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :433.01hCAIX-IN-7
CAS :<p>hCAIX-IN-7 (6c) selectively inhibits tumor-related isoform hCAIX (KI: 410.6 nM) and weakly affects hCAI/II (KI: >10000 nM).</p>Formule :C18H12FNO3Couleur et forme :SolidMasse moléculaire :309.29Carbonic anhydrase inhibitor 13
CAS :<p>Carbonic anhydrase inhibitor 13 (compound 7) is a potent inhibitor of carbonic anhydrase (CA).</p>Formule :C17H15N5O3S2Couleur et forme :SolidMasse moléculaire :401.46hCAIX-IN-3
CAS :<p>hCAII-IN-3 (7e) selectively inhibits CA II/IX with Kis of 124.2/30.5 nM, showing promise for cancer treatment.</p>Formule :C21H21BrN6O4SCouleur et forme :SolidMasse moléculaire :533.4hCAIX-IN-14
CAS :<p>hCAIX-IN-14 is a potent inhibitor of human CA IX with a K i value of 134.8 nM .</p>Formule :C11H17ClN6O2SCouleur et forme :SolidMasse moléculaire :332.81Carbonic anhydrase inhibitor 7
CAS :<p>Potent hCA inhibitor; targets hCA IX, II, XII, I with Ki: 6.5, 7.1, 72.1, 255.8 nM respectively.</p>Formule :C23H17N3O5SCouleur et forme :SolidMasse moléculaire :447.46hCAXII-IN-1
CAS :<p>hCAXII-IN-1 selectively inhibits HCA IX/XII, promising for new cancer drug development.</p>Formule :C20H17NO5Couleur et forme :SolidMasse moléculaire :351.35Quinethazone
CAS :<p>Quinethazone is a thiazide diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.</p>Formule :C10H12ClN3O3SCouleur et forme :Fibrous Crystals From 50% Acetone Physical Description Fibrous Crystals Or White Powder (Ntp 1992)Masse moléculaire :289.74hCAIX-IN-10
CAS :<p>"hCAIX-IN-10 (6i) selectively inhibits carbonic anhydrase IX/XII (Ki: 61.5/586.8 nM), markers in tumor cells, affecting acid-base balance."</p>Formule :C28H21N3O3SCouleur et forme :SolidMasse moléculaire :479.55hCAIX-IN-6
CAS :<p>6B and 14g inhibit tumor-associated HCA IX with low nanomolar potency; 6K targets HCA XII. All are potential cancer drug leads.</p>Formule :C18H12N2O4SCouleur et forme :SolidMasse moléculaire :352.36DTP348
CAS :<p>DTP348: Oral carbonic anhydrase IX inhibitor & hypoxic cell radiosensitizer with sulfamide & 5-nitroimidazole components.</p>Formule :C6H11N5O4SCouleur et forme :SolidMasse moléculaire :249.25Carbonic anhydrase inhibitor 11
CAS :<p>Potent carbonic anhydrase inhibitor VI targets CA II, IX, XII with Ki: 40, 39, 900 nM respectively.</p>Formule :C19H15F3N4O3S2Couleur et forme :SolidMasse moléculaire :468.47hCAIX/XII-IN-4
CAS :<p>hCAIX/XII-IN-4 inhibits CAIX/XII with Ki: 4.5 nM (CAXII), 23.6 nM (CAIX), and >10000 nM (CAI/CAII).</p>Formule :C20H16N2O5Couleur et forme :SolidMasse moléculaire :364.35hCAXII-IN-4
CAS :<p>hCAXII-IN-4 is a selective and potent CA XII inhibitor with a Ki value of 6.4 nM for human CA XII.</p>Formule :C22H27N5O6SCouleur et forme :SolidMasse moléculaire :489.54hCAI/II-IN-2
CAS :<p>hCAI/II-IN-2 (2b) inhibits hCA I/II (Ki: 40.97 nM, 15.15 nM) and IX (61.88 nM), fights AMS with anti-hypoxic effects, but has low cellular activity.</p>Formule :C12H12N4O5S2Couleur et forme :SolidMasse moléculaire :356.38hCA IX-IN-2
<p>hCA IX-IN-2 is a highly potent and selective inhibitor of hCA IX, exhibiting an inhibition constant (K I) value of 32.1 nM and demonstrating anti-proliferative</p>Formule :C23H24N2O4STeCouleur et forme :SolidMasse moléculaire :552.11hCAI/II-IN-3
CAS :<p>"hCAI/II-IN-3 (compound 5b) is a potent dual hCA I/II inhibitor with Ki: 51.25nM (I), 13.15nM (II), helps treat AMS."</p>Formule :C16H18N4O4S2Couleur et forme :SolidMasse moléculaire :394.47hCAIX/XII-IN-6
<p>hCAIX/XII-IN-6: Oral carbonic anhydrase inhibitor, targets hCA I/II/IV/IX/XII, aids rheumatoid arthritis research. Ki: 6697/2950/4093/4.1/7.7 nM.</p>Formule :C26H23N3O6S4Couleur et forme :SolidMasse moléculaire :601.74hCAII-IN-1
CAS :<p>hCAII-IN-1 (7f) inhibits CA II/IX with Kis 1.2 nM/113.6 nM, potential for cancer treatment.</p>Formule :C21H21BrN6O4SCouleur et forme :SolidMasse moléculaire :533.4hCAIX-IN-8
CAS :<p>hCAIX-IN-8, a selective hCAIX inhibitor, IC50: 0.024 μM. Also affects CAII, CAVA (IC50s: 1.99, 1.10 μM), limits cell migration, and induces apoptosis.</p>Formule :C19H16N4O6Couleur et forme :SolidMasse moléculaire :396.35hCAXII-IN-2
CAS :<p>hCAXII-IN-2 is a potent inhibitor of hCA XII (Ki: 84.2 nM) and hCA IX (Ki: 268.5 nM), with low activity on hCA I/II.</p>Formule :C21H18ClN3O4Couleur et forme :SolidMasse moléculaire :411.84hCA I-IN-2
CAS :<p>hCA I-IN-2 (6d) inhibits hCA I (Ki: 18.8 nM) more selectively over II, IX, XII (Ki: 375.1, 1721, 283.9 nM).</p>Formule :C26H20BrN5O3SCouleur et forme :SolidMasse moléculaire :562.44FC11409B
CAS :<p>FC11409B is a CAIX inhibitor, inhibiting breast cancer invasion and metastasis.</p>Formule :C29H23BF4N2O3SCouleur et forme :SolidMasse moléculaire :566.38hCAI/II-IN-4
CAS :<p>hCAI/II-IN-4 inhibits hCA I & II (Ki: 16.95 & 15.22 nM), hCA IX (Ki: 27.04 nM), has anti-hypoxia benefits and is low-toxic for AMS research.</p>Formule :C15H15N3O5S2Couleur et forme :SolidMasse moléculaire :381.43Methazolamide-d6
CAS :<p>Methazolamide-d6 is a GC/LC-MS standard for measuring methazolamide, a glaucoma drug that lowers eye pressure and fluid, reduces seizures, and combats ROS.</p>Formule :C5H2D6N4O3S2Couleur et forme :SolidMasse moléculaire :242.31L 662583
CAS :<p>L 662583 is a topical inhibitor of carbonic anhydrase.</p>Formule :C13H17ClN2O5S3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :412.93L-693612
CAS :<p>L-693612 is an inhibitor of carbonic anhydrase.</p>Formule :C14H24N2O5S3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :396.55L 645151
CAS :<p>L 645151 is an inhibitor of lipophilic CA.</p>Formule :C12H14N2O4S2Couleur et forme :SolidMasse moléculaire :314.38hCAIX-IN-5
CAS :<p>hCAIX-IN-5 was a selective hCAIX inhibitor, inhibiting hCAI, hCAII, hCAIV, and hCAIX with Ki values of >10000, >10000, 130.7, and 829.1 nM, respectively.</p>Formule :C18H12FNO3Degré de pureté :99.26%Couleur et forme :SolidMasse moléculaire :309.29WES-1
CAS :<p>WES-1 (Compound 8g), a carbonic anhydrase IX inhibitor (Ki: 55.9 μM), exhibits broad-spectrum antiproliferative activity against various cancer cell lines,</p>Formule :C20H20N4O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :396.46hCAI/II-IN-6
CAS :<p>hCAI/II-IN-6 is a selective and orally active inhibitor of human carbonic anhydrase (CA).</p>Formule :C19H24N4O3SDegré de pureté :97.07%Couleur et forme :SolidMasse moléculaire :388.48hCAII-IN-9
CAS :<p>hCAII-IN-9 inhibits hCA II/IX/XII with IC50s of 1.18, 0.17, 2.99 μM; not BBB permeable.</p>Formule :C15H16ClN3O5S2Degré de pureté :98.63%Couleur et forme :SolidMasse moléculaire :417.89Sultiame
CAS :<p>Sultiame is an inhibitor of carbonic anhydrase. Sultiame can be used in antiepileptic research.</p>Formule :C10H14N2O4S2Degré de pureté :99.91%Couleur et forme :SolidMasse moléculaire :290.36Carbonic anhydrase inhibitor 6
CAS :<p>Carbonic anhydrase inhibitor 6 is an hCA inhibitor that inhibits hCA IX, hCA II, hCA XII, and hCA I. It is used in the study of lupus erythematosus.</p>Formule :C26H25N3O5SDegré de pureté :98.81%Couleur et forme :SolidMasse moléculaire :491.56hCAIX/XII-IN-8
CAS :<p>hCAIX/XII-IN-8 (compound 3g) is a potent inhibitor of the human carbonic anhydrases (CAs) IX and XII, with inhibition constants (K i) of 8.5 nM for CA IX and 6.</p>Formule :C16H13Cl2N5O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :426.28Carbonic anhydrase inhibitor 12
CAS :<p>CA Inhibitor 12 strongly blocks CA II (K_i 1.72 nM), also inhibits CA I (271 nM), shows anticancer effects.</p>Formule :C27H22BrN5O5S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :640.53N-Desethyl Brinzolamide oxalate
CAS :<p>N-Desethyl Brinzolamide oxalate functions as a dual inhibitor targeting Carbonic anhydrase II and Carbonic anhydrase IV, exhibiting inhibitory concentrations (IC50) of 1.28 nM and 128 nM, respectively [1].</p>Formule :C12H19N3O9S3Couleur et forme :SolidMasse moléculaire :445.49COX-2-IN-30
CAS :<p>COX-2-IN-30, a benzenesulfonamide derivative, is an orally active, dual inhibitor of cyclooxygenase-2 (COX-2; IC50 = 49 nM) and cyclooxygenase-1 (COX-1; IC50 =</p>Formule :C17H16N6O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :384.41hCAIX-IN-16
CAS :<p>hCAIX-IN-16 (Compound 12d), an inhibitor of hCA IX, exhibits inhibition constants (K i) of 190.0 nM for hCA IX and 187.9 nM for hCA XII.</p>Formule :C20H20N8O2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :436.49ALP/Carbonic anhydrase-IN-1
CAS :<p>Compound 1e, also known as ALP/Carbonic anhydrase-IN-1, is a dual inhibitor targeting both carbonic anhydrase (CA) isozymes II, IX, and XII, as well as alkaline</p>Formule :C15H16N2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :224.3CAXII-IN-1
CAS :<p>CAXII-IN-1, antitumor, selectively inhibits CA XII with Ki of 3.8 nM for hCA XII and 56 nM for hCA IX.</p>Formule :C13H7Cl2NO3SCouleur et forme :SolidMasse moléculaire :328.17hCAIX-IN-15
CAS :<p>hCAIX-IN-15 is a potent inhibitor of human carbonic anhydrase IX (hCA IX) with an inhibition constant (Ki) of 38.8 nM, exhibiting broad-spectrum anticancer</p>Formule :C18H14FN7O2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :411.41CAII-IN-2
<p>CAII-IN-2 (3g): potent, selective CA-II inhibitor; IC50-12.1 μM for bovine CA-II; valuable in CA-related disorder research.</p>Formule :C18H19BrN4SCouleur et forme :SolidMasse moléculaire :403.34Carbonic anhydrase inhibitor 5
<p>Potent hCA inhibitor: targets hCA II, IX & XII with IC50s of 42.9, 47.6, & 6.7 nM respectively.</p>Formule :C24H20ClN3O3SCouleur et forme :SolidMasse moléculaire :465.95Carbonic anhydrase inhibitor 9
<p>Carbonic anhydrase inhibitor 9 targets hCA II and IX with Ki of 56.4 and 56.9 nM respectively; shows antiproliferative activity.</p>Formule :C22H20BrN5O4SCouleur et forme :SolidMasse moléculaire :530.39hCAII-IN-5
CAS :<p>hCAII-IN-5 (compound 12h) is a potent, selective inhibitor of human carbonic anhydrase II (hCA II) with an inhibition constant (IC50) of 4.55 µM [1].</p>Formule :C29H18N2O7Couleur et forme :SolidMasse moléculaire :506.46hCAII-IN-3
<p>hCAII-IN-3 inhibits key hCA isoforms with Ki: hCA I (403.8 nM), hCA II (5.1 nM), hCA IX (10.2 nM), hCA XII (5.2 nM); shows anticancer potential.</p>Formule :C17H21N3O3SCouleur et forme :SolidMasse moléculaire :347.43Valerate sodium
CAS :<p>Valerate sodium is a potential Carbonic anhydrase 1/2 inhibitor for biochemical experiments.</p>Formule :C5H9NaO2Degré de pureté :99.84%Couleur et forme :SolidMasse moléculaire :124.11
